Quince Therapeutics announces special shareholder meeting

Reuters2026/07/31 20:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Quince Therapeutics will hold a virtual special shareholder meeting in September 2026.
Votes will be sought to allow conversion of Series C Non-Voting Convertible Preferred Stock into common stock.
Ballots will also cover issuance of common stock tied to warrant exercises and assumed Orphai options.
Shareholders will vote on increasing authorized common shares to 275,000,000 from 250,000,000.
Other items include adopting a 2026 Equity Incentive Plan, a 2026 ESPP, and a potential meeting adjournment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quince Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-328777), on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Quince Therapeutics announces special shareholder meeting

You may also like

Crypto prices